{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:05:28Z","timestamp":1790989528342,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.nefroe.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T09:38:18Z","timestamp":1639474698000},"page":"514-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Jordi","family":"Bover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolt","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn-Malo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Fayos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Lloret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Almad\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2021.11.014_bib0005","first-page":"243","article-title":"Consensus document for the detection and management of chronic kidney disease","volume":"34","author":"Mart\u00ednez-Castelao","year":"2014","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"Suppl 7","key":"10.1016\/j.nefroe.2021.11.014_bib0015","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146801","article-title":"A new data analysis system to quantify associations between biochemical parameters of chronic kidney disease-mineral bone disease","volume":"11","author":"Rodriguez","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","article-title":"Parathyroid hormone. A uremic toxin","volume":"22","author":"Rodriguez","year":"2009","journal-title":"Semin Dial."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ckj\/sfy061","article-title":"Novel insights into parathyroid hormone: report of the parathyroid day in chronic kidney disease","volume":"12","author":"Ure\u00f1a-Torres","year":"2018","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000167193","article-title":"Effect of chronic renal failure on heart. Role of secondary hyperparathyroidism","volume":"6","author":"el-Belbessi","year":"1986","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0050","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.2012.69","article-title":"Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease","volume":"82","author":"Ure\u00f1a Torres","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0065","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","article-title":"Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography","volume":"31","author":"Pilz","year":"2010","journal-title":"Eur Heart J."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0070","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fern\u00e1ndez-Mart\u00edn","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0080","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0090","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2215\/CJN.09280915","article-title":"Bone parameters and risk of hip and femur fractures in patients on hemodialysis","volume":"11","author":"Fishbane","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0110","first-page":"255","article-title":"Differences in calcium kinetic pattern between CAPD and HD patients","volume":"44","author":"Kurz","year":"1995","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.nefro.2016.05.021","article-title":"Detecci\u00f3n de las calcificaciones vasculares: \u00bfuna herramienta \u00fatil para el nefr\u00f3logo?","volume":"36","author":"Bover","year":"2016","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2020","journal-title":"Nephrol DIal Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0130","series-title":"Parathyroid glands in chronic kidney disease","first-page":"103","article-title":"Relation between PTH and biochemical markers of MBD","author":"Ure\u00f1a-Torres","year":"2020"},{"key":"10.1016\/j.nefroe.2021.11.014_bib0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00223-018-0399-z","article-title":"Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders","volume":"103","author":"Bover","year":"2018","journal-title":"Calcif Tissue Int."},{"issue":"4","key":"10.1016\/j.nefroe.2021.11.014_bib0140","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00223-020-00781-5","article-title":"The non-invasive diagnosis of bone disorders in CKD","volume":"108","author":"Bover","year":"2021","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00774-014-0639-x","article-title":"Chronic kidney disease and bone metabolism","volume":"33","author":"Kazama","year":"2015","journal-title":"J Bone Miner Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism","volume":"9","author":"Kuro-o","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0160","series-title":"The kidney","first-page":"2103","article-title":"Renal osteodystrophies","author":"Llach","year":"2000"},{"key":"10.1016\/j.nefroe.2021.11.014_bib0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease \u2014 mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0180","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0185","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0190","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0195","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0200","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0205","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00223-017-0333-9","article-title":"Fibroblast growth factor (FGF) 23 regulates the plasma levels of parathyroid hormone in vivo through the FGF receptor in normocalcemia, but not in hypocalcemia","volume":"102","author":"Mace","year":"2018","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0215","first-page":"63","article-title":"The response to the infusion of parathyroid extract in hypocalcaemic states","volume":"31","author":"Evanson","year":"1966","journal-title":"Clin Sci."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0220","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ki.1976.60","article-title":"Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3","volume":"9","author":"Massry","year":"1976","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-41-2-339","article-title":"Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure. A possible cause for secondary hyperparathyroidism","volume":"41","author":"Llach","year":"1975","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ki.1985.48","article-title":"Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D","volume":"27","author":"Wilson","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0245","first-page":"377","article-title":"Renal osteitis fibrosa cystica","volume":"60","author":"Albright","year":"1937","journal-title":"Bull Johns Hopkins Hosp."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archinte.1969.00300150061009","article-title":"Calcium, phosphorus, and bone in renal disease and transplantation","volume":"123","author":"Bricker","year":"1969","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0255","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited","volume":"25","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0260","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1053\/ajkd.2001.27426","article-title":"Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases","volume":"38","author":"Fukagawa","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ki.1978.116","article-title":"Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites","volume":"14","author":"Somerville","year":"1978","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0270","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0275","first-page":"152","article-title":"Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3","volume":"94","author":"Massry","year":"1979","journal-title":"J Lab Clin Med."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0280","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ki.1987.279","article-title":"Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone","volume":"32","author":"Galceran","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0285","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ki.1979.165","article-title":"Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention","volume":"16","author":"Somerville","year":"1979","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0290","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ki.1994.129","article-title":"Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat","volume":"45","author":"Bover","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0295","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S8756-3282(99)00169-6","article-title":"Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus","volume":"25","author":"Bover","year":"1999","journal-title":"Bone."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0300","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","article-title":"On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency","volume":"61","author":"Llach","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0305","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0310","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jbmr.5650060508","article-title":"Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts","volume":"6","author":"Yates","year":"1991","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0315","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13662","article-title":"Structural mechanism of ligand activation in human calcium-sensing receptor","volume":"5","author":"Geng","year":"2016","journal-title":"Elife."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0320","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0325","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","article-title":"The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia","volume":"46","author":"Bover","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0330","first-page":"E918","article-title":"Desensitization of calcium messenger system in parathyroid hormone-stimulated opossum kidney cells","volume":"264","author":"Fujimori","year":"1993","journal-title":"Am J Physiol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF02411275","article-title":"Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia","volume":"34","author":"Olgaard","year":"1982","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0340","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/endo-111-5-1678","article-title":"Extraction of parathyroid hormone and release of adenosine 3\u2019,5\u2019-monophosphate by isolated perfused bones obtained from dogs with acute uremia","volume":"111","author":"Olgaard","year":"1982","journal-title":"Endocrinology."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0345","series-title":"Textbook of endocrinology","first-page":"41","article-title":"Endocrine systems: mechanisms of disease, target cells, and receptors","author":"Roth","year":"1981"},{"key":"10.1016\/j.nefroe.2021.11.014_bib0350","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF00866780","article-title":"Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia","volume":"10","author":"Dr\u00fceke","year":"1996","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0355","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0360","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0365","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/endo.133.2.8393771","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues","volume":"133","author":"Ure\u00f1a","year":"1993","journal-title":"Endocrinology."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0370","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0375","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","article-title":"The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure","volume":"45","author":"Ure\u00f1a","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000168684","article-title":"PTH-PTHrP receptor mRNA is downregulated in chronic renal failure","volume":"14","author":"Tian","year":"1994","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0385","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/ndt\/11.10.2008","article-title":"PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats","volume":"11","author":"Ure\u00f1a","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0390","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/ki.1995.248","article-title":"Parathyroidectomy does not prevent the renal PTH\/PTHrP receptor down-regulation in uremic rats","volume":"47","author":"Ure\u00f1a","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0395","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fphys.2017.00776","article-title":"PTH reloaded: a new evolutionary perspective","volume":"8","author":"Suarez-Bregua","year":"2017","journal-title":"Front Physiol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0400","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/11.7.1292","article-title":"Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism","volume":"11","author":"Berdud","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0405","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0009-8981(76)90313-2","article-title":"The effect of uraemic metabolites on parathyroid extract-induced bone resorption in vitro","volume":"73","author":"Wills","year":"1976","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0410","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ki.1991.118","article-title":"Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma","volume":"39","author":"Andress","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0415","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1523-1755.2004.00472.x","article-title":"Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106\u201301 osteoblast-like cells","volume":"65","author":"Disthabanchong","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0420","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0425","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40620-017-0397-7","article-title":"Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease","volume":"30","author":"Massy","year":"2017","journal-title":"J Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0430","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jbmr.312","article-title":"Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids","volume":"26","author":"Sage","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0435","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/CS20190779","article-title":"Inflammation both increases and causes resistance to FGF23 in normal and uremic rats","volume":"134","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"Clin Sci (Lond)."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0440","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast differentiation and function","volume":"27","author":"Mozar","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0445","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5935\/0101-2800.20140042","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J Bras Nefrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0460","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41581-019-0111-1","article-title":"Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling","volume":"15","author":"Nigam","year":"2019","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0465","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0475","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands","volume":"26","author":"Murray","year":"2005","journal-title":"Endocr Rev."},{"issue":"Suppl 2","key":"10.1016\/j.nefroe.2021.11.014_bib0480","first-page":"12","article-title":"The PTH\/PTHrP receptor: biological implications","volume":"23","author":"Ure\u00f1a","year":"2003","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0485","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.2691","article-title":"Xeno-Klotho. Inhibits parathyroid hormone signaling","volume":"31","author":"Takenaka","year":"2016","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0490","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI133473","article-title":"Parathyroid-hormone-dependent bone formation requires butyrate production by intestinal microbiota","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0495","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jbmr.2323","article-title":"N-cadherin restrains PTH activation of Lrp6\/B-catenin signaling and osteoanabolic action","volume":"30","author":"Revollo","year":"2015","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0500","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0505","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0510","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0515","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000446278","article-title":"Sclerostin and bone aging: a mini-review","volume":"62","author":"Hay","year":"2016","journal-title":"Gerontology."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.10.019","article-title":"Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans","volume":"59","author":"Roforth","year":"2014","journal-title":"Bone."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0525","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0530","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0535","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0540","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","article-title":"Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients","volume":"99","author":"Kanbay","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0545","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0550","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0555","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ndt\/11.5.813","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0560","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0565","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0570","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/TP.0000000000001311","article-title":"Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism","volume":"100","author":"Evenepoel","year":"2016","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0575","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ki.1991.263","article-title":"Sigmoidal relationship between calcitonin and calcium: studies in normal, parathyroidectomized, and azotemic rats","volume":"40","author":"Torres","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0580","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0272-6386(12)80749-9","article-title":"The relationship between serum calcitonin and calcium in the hemodialysis patient","volume":"21","author":"Felsenfeld","year":"1993","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0585","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ki.1991.203","article-title":"Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0590","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/oxfordjournals.ndt.a090857","article-title":"Effect of calcitriol replacement on serum calcitonin and parathyroid hormone levels in CAPD patients","volume":"10","author":"Quesada","year":"1995","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0595","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/jc.2012-4003","article-title":"Pharmacodynamics of cinacalcet over 48 hours in patients with controlled secondary hyperparathyroidism: useful data in clinical practice","volume":"98","author":"Arenas","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0600","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MNH.0b013e328362141e","article-title":"New insights in regulation of calcium homeostasis","volume":"22","author":"Felsenfeld","year":"2013","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0605","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0610","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1681\/ASN.V112330","article-title":"Race is a major determinant of secondary hyperparathyroidism in uremic patients","volume":"11","author":"Gupta","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0615","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0620","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.1997.12.6.958","article-title":"Resistance to bone resorbing effects of PTH in black women","volume":"12","author":"Cosman","year":"1997","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0625","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"10.1016\/j.nefroe.2021.11.014_bib0630","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.kint.2020.04.013","article-title":"Clinical evidence of direct bone effects of cinacalcet","volume":"98","author":"Jorgensen","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0635","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","article-title":"Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration","volume":"95","author":"D\u00edaz-Tocados","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0640","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5301\/jn.5000187","article-title":"Bone-vascular cross-talk","volume":"25","author":"London","year":"2012","journal-title":"J Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0645","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0650","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1681\/ASN.2014020169","article-title":"Ankle-Brachial index and bone turnover in patients on dialysis","volume":"26","author":"London","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0655","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0660","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: the role of suppressed parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int."},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2021.11.014_bib0665","first-page":"3","article-title":"Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0670","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Nefrolog\u00eda para el manejo de las alteraciones del metabolismo \u00f3seo-mineral en los pacientes con enfermedad renal cr\u00f3nica 2020 (SEN-MM)","author":"Torregrosa","year":"2021","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0675","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3747\/pdi.2013.00110","article-title":"Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis","volume":"34","author":"Rhee","year":"2014","journal-title":"Perit Dial Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0680","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ckj\/sfz187","article-title":"Evidence in chronic kidney disease \u2013 mineral and bone disorder guidelines: is it time to treat or time to wait?","volume":"13","author":"Bover","year":"2020","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0685","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41581-020-0295-4","article-title":"Ethical challenges in nephrology: a call for action","volume":"16","author":"Martin","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0690","first-page":"22","article-title":"Parathyroid hormone signaling in osteocytes","volume":"2","author":"Wein","year":"2018","journal-title":"J Bone Miner Res Plus."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0695","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI110067","article-title":"Insulin resistance in uremia","volume":"67","author":"DeFronzo","year":"1981","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0700","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01453697","article-title":"Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia","volume":"5","author":"Blum","year":"1991","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0705","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000346791","article-title":"Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis","volume":"180","author":"Koizumi","year":"2013","journal-title":"Contrib Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0710","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0715","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/en.2011-1770","article-title":"Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats","volume":"153","author":"Rom\u00e1n-Garc\u00eda","year":"2012","journal-title":"Endocrinology."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0720","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0725","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0730","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1989.3","article-title":"1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs","volume":"35","author":"Brown","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0735","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","article-title":"Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor","volume":"60","author":"Ritter","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2021.11.014_bib0740","series-title":"Parathyroid glands in chronic kidney disease","first-page":"51","article-title":"PTH receptors and skeletal resistance to PTH action","author":"Bover","year":"2020"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142100122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142100122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:46:55Z","timestamp":1761853615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S201325142100122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S201325142100122X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.11.014","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2020.12.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}